+375 (212) 36-47-77
EN RU

Catalog

INJECTION PREPARATIONS

  • Solution for infusion.
    Analgesic non-narcotic drug.

    Paracetamol has analgesic, antipyretic and mild anti-inflammatory effects.

  • Solution for intravenous administration.

    1 ml of Hemastad-Rn solution contains:
    active substance: tranexamic acid - 50 mg
    excipients: water for injection - up to 1 ml.

  • Injection.

    Means for the treatment of liver diseases.
    1 ml of solution contains:
    active substance: L-ornithine L-aspartate - 100 mg;
    and excipients.

  • Composition:
    1 bottle contains:
    active substance: thiamine hydrochloride - 100.0 mg, pyridoxine hydrochloride - 100.0 mg, cyanocobalamin 1.0 mg, lidocaine hydrochloride - 20.0 mg;
    excipients: benzyl alcohol - 40.0 mg, sodium polyphosphate - 20.0 mg, potassium ferricyanide - 0.2 mg, sodium hydroxide - up to pH 4.0-5.0, water for injection - up to 2 ml.

  • Composition:
    1 bottle contains:
    active substance: thioctic acid - 600 mg;
    excipients: trometamol, water for injection - up to 24 ml.

LIQUID MEDICINAL FORMS

  • Medical device
    Nasal spray.

    Hygienic care for the nasal cavity of infants, children and adults.

  • Composition:
    1 ml of solution contains:
    active substance: xylometazoline hydrochloride 0.50 mg or 1.00 mg;
    excipients: sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, disodium edetate, benzalkonium chloride, sorbitol, sodium chloride, hypromellose, purified water.

  • Composition:
    1 ml of nasal spray contains:
    active substance: xylometazoline hydrochloride 1.00 or 0.50 mg;
    excipients: sodium dihydrogen phosphate, disodium phosphate dihydrate, disodium edetate, benzolconium chloride, sorbitol, sodium chloride, hypromellose, purified water.

  • Composition:
    1 ml of nasal spray contains:
    active substance: xylometazoline hydrochloride 1.00 or 0.50 mg;
    excipients: sodium dihydrogen phosphate, disodium phosphate dihydrate, disodium edetate, benzolconium chloride, sorbitol, sodium chloride, hypromellose, purified water.

  • Composition:
    1 ml of solution contains:
    active substance: naphazoline nitrate-1.00 mg;
    excipients: boric acid, disodium edetate, sodium chloride, benzalkonium chloride, sodium hydroxide, purified water.

  • Composition:
    1 ml of solution contains:
    active substance: naphazoline nitrate-1.00 mg;
    excipients: boric acid, disodium edetate, sodium chloride, benzalkonium chloride, eucalyptus oil, macrogolglycerol hydroxystearate, sodium hydroxide, purified water.

  • Composition:
    1 ml of solution contains:
    active substances: phenylephrine (in the form of phenylephrine hydrochloride) - 2.50 mg, dimethindene maleate - 0.25 mg.
    excipients: benzalkonium chloride, anhydrous citric acid, disodium phosphate dihydrate, sorbitol, lavender oil, purified water.

  • Composition:
    1 ml of solution contains:
    active substance: oxymetazoline hydrochloride - 0.50 mg;
    excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, purified water.

  • Composition:
    1 ml of solution contains:
    active substance: oxymetazoline hydrochloride - 0.50 mg;
    excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, menthol, macrogolglycerol hydroxystearate, purified water.

  • Composition:
    1 ml of solution contains:
    active substance: oxymetazoline hydrochloride 0.10 mg, or 0.25 mg, or 0.50 mg; excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, purified water.

  • Composition:
    1 ml of solution contains:
    active substance: oxymetazoline hydrochloride 0.10 mg, or 0.25 mg, or 0.50 mg; excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, purified water.

  • Composition:
    1 ml of solution contains:
    active substance: oxymetazoline hydrochloride 0.10 mg, or 0.25 mg, or 0.50 mg; excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, purified water.

  • Composition:
    1 ml drops for oral administration contains:
    active substance: 1 mg dimethindene maleate;
    excipients: disodium phosphate dihydrate, citric acid monohydrate, benzoic acid, disodium edetate, sodium saccharin, propylene glycol, purified water.

  • Magnesol contains magnesium and is used to correct deficiency of this element in the body. The combination of several symptoms may indicate  deficiency of magnesium in the body.

  • Nasal drops.

    1 ml of the solution contains: phenylephrine 2.5 mg, dimethindene maleate 0.25 mg.
    Combination drug of vasoconstrictive and antiallergic ingredients.

  • Ear drops

    Contains: phenazone 40 mg, lidocaine hydrochloride 10 mg.
    Anti-inflammatory and analgesic agent.

  • Lyophilizate for the preparation of nasal drops.

    Contains: interferon human recombinant alpha-2b 1mln IU.
    Antiviral agent for intranasal and inhalation use.

SOFT DRUGS FORMS

  • The composition of the drug:
    1 suppository Ruferon-Rn 150,000 IU contains:
    active component: interferon human recombinant alpha-2b with an activity of 150,000 IU; excipients: ascorbic acid, glycerol monostearate, solid fat.
    1 suppository Ruferon-Rn 250,000 IU contains:
    active component: interferon human recombinant alpha-2b with an activity of 250,000 IU, excipients: ascorbic acid, glycerol monostearate, solid fat.

  • The composition of the drug:
    1 suppository Ruferon-Rn 500000 IU contains:
    active substance: interferon human recombinant alpha-2b activity of 500,000 IU
    excipients: ascorbic acid, glycerol monostearate, solid fat.
    1 suppository Ruferon-Rn 1,000,000 IU contains:
    active substance: interferon human recombinant alpha-2b activity of 1,000,000 IU
    excipients: ascorbic acid, glycerol monostearate, solid fat.

  • The composition of the drug:
    1 suppository Ruferon-Rn 150,000 IU contains:
    active component: interferon human recombinant alpha-2b with an activity of 150,000 IU; excipients: ascorbic acid, glycerol monostearate, solid fat.
    1 suppository Ruferon-Rn 250,000 IU contains:
    active component: interferon human recombinant alpha-2b with an activity of 250,000 IU, excipients: ascorbic acid, glycerol monostearate, solid fat.

  • The composition of the drug:
    1 suppository Ruferon-Rn 500000 IU contains:
    active substance: interferon human recombinant alpha-2b activity of 500,000 IU
    excipients: ascorbic acid, glycerol monostearate, solid fat.
    1 suppository Ruferon-Rn 1,000,000 IU contains:
    active substance: interferon human recombinant alpha-2b activity of 1,000,000 IU
    excipients: ascorbic acid, glycerol monostearate, solid fat.

  • Vaginal suppositories

    Contains: Sertaconazole Nitrate 300 mg.
    Antifungal agent for the topical use in gynenology.

  • Vaginal suppositories

    Contains: metronidazole 100 mg, miconazole nitrate 100 mg.
    Combination drug with antimicrobial, antiprotozoal and antifungal action for use in gynecology.

  • Vaginal suppositories

    Contains: metronidazole 500 mg, miconazole nitrate 100 mg.
    Combination drug with antimicrobial, antiprotozoal and antifungal action for use in gynecology.

  • Vaginal suppositories

    Contains: povidone-iodine 200 mg.
    Antiseptic agent for the treatment of gynecological diseases.

  • Vaginal suppositories

    Contains: dexpanthenol 100 mg, chlorhexidine bigluconate 16 mg.
    Combination drug for topical use in gynecology, has a regenerative, antiseptic and metabolic action.

  • Vaginal suppositories

    Contains: natamycin 100 mg.
    Topical antifungal agent for use in gynecology.

  • Vaginal suppositories

    Contains: miconazole nitrate 100 mg
    Antifungal drug for use in gynecology.

  • Vaginal suppositories

    Contains: lactobacillus acidophilus 107 CFU
    Probiotic agent of the topical use in gynecology.

  • Rectal suppositories

    Contains: bisacodyl 10 mg.
    Laxative.

  • Rectal suppositories

    Contains: ibuprofen 60 mg.
    Non-steroidal anti-inflammatory drug.

  • Vaginal suppositories

    Contains: chlorhexidine digluconate 16 mg.
    Antiseptic medicinal product for topical use in gynecology.

SOLID MEDICINAL FORMS

  • Composition:
    1 tablet Moxodine 0.2 mg contains:
    active substance: moxonidine - 0.2 mg
    excipients: microcrystalline cellulose, povidone K 30, sodium starch glycolate (type A), magnesium stearate, lactose monohydrate, shell: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc.
    1 tablet Moxodine 0.4 mg contains:
    active substance: moxonidine - 0.4 mg
    excipients: microcrystalline cellulose, povidone K 30, sodium starch glycolate (type A), magnesium stearate, lactose monohydrate, shell: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc.

  • Composition:
    1 tablet Moxodine 0.2 mg contains:
    active substance: moxonidine - 0.2 mg
    excipients: microcrystalline cellulose, povidone K 30, sodium starch glycolate (type A), magnesium stearate, lactose monohydrate, shell: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc.
    1 tablet Moxodine 0.4 mg contains:
    active substance: moxonidine - 0.4 mg
    excipients: microcrystalline cellulose, povidone K 30, sodium starch glycolate (type A), magnesium stearate, lactose monohydrate, shell: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc.

  • Tablets

    Composition per tablet:
    active substance: valganciclovir - 450 mg (as valganciclovir hydrochloride - 496.3 mg);
    excipients: microcrystalline cellulose, crospovidone, povidone K30, magnesium stearate; shell (polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc).

  • Tablets

    1 tablet of 250 mg contains:
    active substance: tranexamic acid - 250 mg;
    and excipients.

  • Tablets

    1 tablet of 500 mg contains:
    active substance: tranexamic acid - 500 mg;
    and excipients.

  • Composition per tablet:
    active substance: ibuprofen 200 mg;
    excipients: microcrystalline cellulose, anhydrous colloidal silicon dioxide, magnesium stearate, corn starch, shell (polyvinyl alcohol, macrogol, talc, titanium dioxide).

  • Composition per tablet:
    active substance: diosmin 600 mg;
    excipients: microcrystalline cellulose, croscarmellose sodium, hypromellose, magnesium stearate.

  • Sonex Tablets

    Contains: Zopiclone 7.5 mg.
    Sleeping and sedative drug
    Used to treat severe sleep disorders: situational and / or temporary insomnia.

  • Lozenges

    Contains: dry extract of Salvia L. leaves 12.5 mg
    Agent with a topical anti-inflammatory effect.

  • Tablets

    Contains: nifuroxazide 100 mg
    Antimicrobial agent for the treatment of intestinal infections.

  • Dispersible tablets

    Contains: smectite dioctahedral 750 mg.
    Antidiarrhoeal drug, sorbent.

  • Tablets

    Contains: Ornidazole 500 mg.
    Antiprotozoal agent.

  • Tablets

    Contains: nimesulide 100 mg.
    Non-steroidal anti-inflammatory drug.

  • Tablets

    Contains: melatonin 3 mg.
    Sleeping and sedative agent.

  • Tablets

    Contains: magnesium lactate dihydrate 334 mg, equivalent to 34 mg of magnesium, pyridoxine hydrochloride 5 mg.
    Combination drug of magnesium and vitamin B6.

  • Lozenges.

    Contains: cetylpyridinium chloride 1.5 mg
    Topical antiseptic for the mouth and throat.

  • Tablets

    Contains: ibuprofen 400 mg.
    Non-steroidal anti-inflammatory drug.

  • Coated tablets

    Contains: dry extract of the Silybum marianum fruits, equivalent to 35 mg of silymarin.
    Hepatoprotector of plant origin.

  • Tablets

    Contains: diosmin 450 mg.
    Venotonic and angioprotective agent.

  • Lozenges

    Contains: chlorhexidine 2 mg, tetracaine 0.2 mg, ascorbic acid 50 mg.
    Local antiseptic medicinal product with an analgesic effect.

Rubikon 2020
Site development: One Click